New workstream focused on leveraging Generative AI (GenAI) to support the drafting of audit findings . This initiative is part of a broader shift from exploratory discussions to structured implementation of GenAI in quality assurance.

Goal

To share the approach, key learnings, benefits and considerations when implementing GenAI for drafting audit reports, giving other biopharma companies a head-start in doing the same.

Expected Outcomes

  • White paper which will describe best practices and technical implementation guidance for using GenAI to generate the first draft of audit report content. Additional topics include use case identification/scoping, value definition, guardrails, risks, and infrastructure needs.
  • Connections with additional future white papers on leveraging GenAI on topics such as validation
  • Leveraging of additional channels such as podcasts, industry conferences, and connections to existing IMPALA work.

Lead(s)

Resources